← k3vl4r
Log inGet started →

XENE (Xenon Pharmaceuticals) Price Forecast

AI-generated price forecast for Xenon Pharmaceuticals (XENE) across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.

The desk streams live daily· see the schedule →

As of August 2026: K3vl4r's AI model currently reads XENE as 2/2 bearish · strong across its horizons (0 of 2 timeframes pointing up), with a last price of 62.88. See our public, auditable track record →

📈 Daily Top Picks beating the S&P 500 since launch→✓ Public, verifiable track record Live system status💎 Get the full AI report · pay with XRP

Last price

62.88

AI outlook

2/2 bearish · STRONG

Timeframes up

0 / 2

Share𝕏PostTelegram

XENE forecast by horizon

HorizonDirectionProjected move (end of horizon)Bullish prob.
1-hour———
4-hour~6 weeks out———
Daily~4 months out▼ Down-28.64%—
Weekly~1.9 years out▼ Down-30.71%—

Latest XENE news

From the market-news feed the forecasts are read against.

  • Xenon Pharmaceuticals (XENE) Q2 2026 Earnings Call Transcript · Motley Fool · Aug 13
  • Xenon Pharmaceuticals (NASDAQ:XENE) Presents High-Quality Technical Breakout Setup · ChartMill · Aug 13
  • Xenon Pharmaceuticals: Strong Buy On Azetukalner NDA And MDD Expansion Opportunity · SeekingAlpha · Aug 11
  • Xenon Pharmaceuticals' Azetukalner NDA Filing Remains on Track After FDA Meeting, RBC Says · MT Newswires · Aug 7
  • RBC Capital Maintains Outperform on Xenon Pharmaceuticals, Lowers Price Target to $81 · Benzinga · Aug 7

🔒

See the full XENE forecast

Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.

Create a free account →

Already have one? Log in

XENE forecast — frequently asked

Will XENE go up?

K3vl4r's AI model currently reads XENE as 2/2 bearish · STRONG — 0 of 2 forecast horizons point up, so the overall read is leaning to the downside. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What is the XENE price prediction for 2026?

K3vl4r's model projects XENE toward $62.13 over the next ~4 months, a -0.3% move from $62.31. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What price could XENE reach?

Over its longest horizon (~~1.9 years), the model's projected target for XENE is $62.26 (-0.3% vs $62.46). Confidence decreases the further out the horizon, so treat longer-range targets as one scenario, not a guarantee. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

Part of Healthcare forecasts — browse the full sector.

More AI forecasts

HALOVNRXMLTXEOLSHYPDWGSCELCPCVXACRVRCUSALVORVMDSNDAEWTX

Will XENE reach…?

Will XENE reach $100.00?Will XENE reach $200.00?Will XENE reach $250.00?Will XENE reach $500.00?

Or see the full XENE price prediction (2027–2040), or the forecast for today, tomorrow and this week.

Compare XENE

XENE vs HALOXENE vs VNRXXENE vs MLTXXENE vs EOLSXENE vs HYPDXENE vs WGS

Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.

K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.

Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.

StreamWatch on Kick·Watch on YouTube
k3vl4rTop PicksTrack recordChart indicatorsToday's outlookStream scheduleBiggest moversMarket heatmapForecasts by sectorAI reportsMarket videosCompareMethodologyBest AI toolsAboutFAQ◈ KVLHow KVL worksTokenomicsPricingX (Twitter)YouTube — daily showsTikTokTwitch — live forecastingDiscord community

Join the community on Discord and catch the desk stream live on Kick or YouTube. Create a free account →

Forecasts are AI-generated; written analysis is AI-assisted and human-reviewed. Informational only, not financial advice. See Terms, Risk Disclosure, Privacy · Methodology · Status.